Remembrane is proud to announce a new technological partnership with Expres2ion Biotechnologies, showing once more its commitment to improving and offering ultimate solutions for your research projects. With expertise in Drosophila Schneider-2 (S2) cells, Expres2ion Biotechnologies provides contract research and manufacturing exploiting a non-viral Drosophila S2 expression technology for the production of recombinant proteins for research, preclinical development and for use in clinical trials. For more information, visit http://www.expres2ionbio.com/.